Metronomic cyclophosphamide and methotrexate for breast cancer: Enhanced efficacy by adding dalteparin and low-dose prednisone?

被引：1
|
作者：
Buckman, Robert [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada
来源：
BREAST | 2011年 / 20卷 / 05期
关键词：
D O I：
10.1016/j.breast.2011.06.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：483 / 484
页数：2
相关论文
共 50 条
  • [1] LOW-DOSE METRONOMIC CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE AND METHOTREXATE IN METASTATIC BREAST CANCER PATIENTS
    Krajnak, S.
    Battista, M.
    Elger, T.
    Stewen, K.
    Heimes, A. S.
    Hasenburg, A.
    Schmidt, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 116 - 116
  • [2] LOW-DOSE METRONOMIC CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE AND METHOTREXATE IN METASTATIC BREAST CANCER PATIENTS
    Krajnak, S.
    Battista, M.
    Elger, T.
    Stewen, K.
    Heimes, A. S.
    Hasenburg, A.
    Schmidt, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 636 - 636
  • [3] Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer Patients
    Krajnak, Slavomir
    Battista, Marco
    Brenner, Walburgis
    Almstedt, Katrin
    Elger, Tania
    Heimes, Anne-Sophie
    Hasenburg, Annette
    Schmidt, Marcus
    BREAST CARE, 2018, 13 (04) : 272 - 276
  • [4] Study of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer
    Kudo, Shun
    Hasunuma, Ayako
    Ahiko, Yuka
    Makino, Takatoshi
    ANNALS OF ONCOLOGY, 2015, 26 : 128 - 128
  • [5] Low-dose "metronomic chemotherapy" with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit
    Masci, G.
    Losurdo, A.
    Gandini, C.
    Garassino, I.
    di Tommaso, L.
    Torrisi, R.
    Zuradelli, M.
    Santoro, A.
    ECANCERMEDICALSCIENCE, 2012, 6
  • [6] Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer:: antitumor activity and biological effects
    Colleoni, M
    Orlando, L
    Sanna, G
    Rocca, A
    Maisonneuve, P
    Peruzzotti, G
    Ghisini, R
    Sandri, MT
    Zorzino, L
    Nolè, F
    Viale, G
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 232 - 238
  • [7] Low-dose metronomic oral cyclophosphamide plus prednisone for metastatic castration resistant prostate cancer (mCRPC) patients
    Martinez Lago, N.
    Anido, U.
    Vieito, M.
    Varela-Ponte, R.
    Carmona, M.
    Rodriguez, C.
    Cortegoso, A.
    Candamio, S.
    Lopez-Lopez, R.
    Leon, L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S705 - S706
  • [8] Low-dose methotrexate and cyclophosphamide in recurrent ovarian cancer
    Scheusan, R.
    Curescu, S.
    Stanculeanu, D.
    Curescu, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] SAFETY AND EFFICACY OF VINORELBINE PLUS LOW-DOSE METRONOMIC CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINES AND TAXANES
    Kudo, S.
    Makino, T.
    Hasunuma, A.
    Ahiko, Y.
    ANNALS OF ONCOLOGY, 2014, 25
  • [10] Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study.
    Martinez Lago, Nieves
    Anido Herranz, Urbano
    Leon Mateos, Luis
    Vieito, Maria
    Varela Ponte, Rafael
    Aguin Losada, Santiago
    Brozos Vazquez, Elena
    Carmona Campos, Marta
    Rodriguez Lopez, Carmela
    Cortegoso Mosquera, Alexandra Sabela
    Candamio Folgar, Sonia
    Lopez Lopez, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345